🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users injecting substances of unknown origin.

Several professionals said the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Elimination

Based on the social media company, the service has taken down violative material and prohibited associated hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also found groups with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.

After minutes of joining one community, a vendor posted contact information, where most purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Inside these communities, posts show dark colored packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has already seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially serious medical dangers”.